Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2007 Apr;61(4):711–712. doi: 10.1111/j.1742-1241.2007.01357.x

Errata

PMCID: PMC2253718

Original paper ‘Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: the LAURA study’. Int J Clin Pract 2006; 60: 1364–70.

Since publication, an error has been spotted in table 2 which meant that the percentage symbol was excluded. The corrected table is detailed below.

Table 2.

Characteristics of the study population at baseline (n = 3175)

Variables
Biodemographic data
    Sex (male/female) (%) M: 49 F: 51
    Age (years), mean ± SD 63±10
    BMI (kg/m2), mean ± SD M: 28.2±3.8 F: 28.3±4.2
    Waist circumference (cm), mean ± SD M: 101.3 ± 12.2 F: 96.8±14.1
Cardiovascular risk factors (%)
    Grade I hypertension 43
    Grade II hypertension 57
    Hypercholesterolemia 32
    Current smoking 30
    Family history cardiovascular disease 16
    Diabetes mellitus 15
Target organ damage (%)
    Left ventricular hypertrophy 18
    Atherosclerotic plaques 7
    Mild renal impairment/microalbuminuria 5
Associated clinical conditions (%)
    Ischaemic heart disease 10
    Peripheral arterial disease 6
    Congestive heart failure 4
    Renal failure 4
    Cerebrovascular disease 3
    Advanced retinopathy 1
Cardiovascular risk (%)
    Low risk 7.5
    Medium risk 44
    High 22.7
    Very high 25.8
Clinical data (mean ± SD)
    SBP (mmHg) 159.5 ± 11.7
    DBP (mmHg) 95.2 ± 7.4
    Heart rate (bpm) 68.4 ± 4.2

M, male; F, female; BMI, body mass index; SBP, systolic blood pressure; DPB, diastolic blood pressure.

Reference

  • 1.Barrios V. Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: the LAURA study’. Int J Clin Pract. 2006;60:1364–70. doi: 10.1111/j.1742-1241.2006.01176.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Clinical Practice are provided here courtesy of Wiley

RESOURCES